MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Online Webinar on FDA's Guidance on Financial Disclosure by Clinical Investigators in September

Event Details

Online Webinar on FDA's Guidance on Financial Disclosure by Clinical Investigators in September

Time: September 21, 2016 from 10am to 11am
Location: Online Event
Street: 161 Mission Falls Lane, Suite 216
City/Town: Fremont
Website or Map: http://bit.ly/2aa1gix
Phone: 18004479407
Event Type: webinar
Organized By: Adam Fleming
Latest Activity: Jul 26, 2016

Export to Outlook or iCal (.ics)

Event Description

Overview:
This webinar will provide an overview and guidance to firms that are either going through or preparing to go through clinical trials and working with clinical investigators.

Earlier this year (Spring 2011), FDA released its draft guidance to replace its current guidance on disclosure of financial interests held by clinical investigators. The draft guidance reflects the changing landscape both within and outside FDA regarding transparency of financial interests.

Areas Covered in the Session:
Review proposed changes to the 2011 released draft guidance
Clarification on definition of sponsor
Understand FDA’s clear actions that can and will be taken regarding refuse to file a marketing application
Learn how to submit financial disclosure information to FDA
Why FDA is expounding on due diligence and its significance
Timing of data collection and purpose
Understand how financial information should be disclosed to FDA
Update regarding financial disclosure questionnaires
Time period covered by regulations
Clarification on covered clinical study
Factors for FDA review of disclosed financial interests

Who Will Benefit:
The employees who will benefit include: All levels of management and departmental representatives and those who desire a better understanding with FDA’s draft guidance on financial disclosure by clinical investigators, including:
Regulatory Affairs
Clinical Affairs
Investigators
Quality and Compliance
Marketing & Sales
Distributors/Authorized Representatives
Legal Counsel
Consultants

Speaker Profile:
David R. Dills , Global Regulatory Affairs & Compliance Consultant, has an accomplished record with more than 26 years of experience within regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVDs, and bio/pharmaceutical manufacturers on the global landscape.

Contact Detail:

Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
http://www.compliance4all.com/
Event Link : http://bit.ly/2aa1gix
Twitter Follow us – https://twitter.com/compliance4all
Facebook Like us – https://www.facebook.com/Compliance4all
Pinterest - https://in.pinterest.com/compliance4all/

Comment Wall

Comment

RSVP for Online Webinar on FDA's Guidance on Financial Disclosure by Clinical Investigators in September to add comments!

Join MedTech I.Q.

Attending (1)

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service